Dagny Stuart

W. Kimryn Rathmell, MD, PhD, Cornelius A. Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), has been elected to the nominating committee for the American Society of Clinical Oncology (ASCO). Read More

Amanda Mathis, chief financial officer of Bridgestone Americas, was just 35 when she first felt a lump in her right breast. Read More

An artist with strong ties to Nashville has donated artwork to Vanderbilt-Ingram Cancer Center’s (VICC) Radiation Oncology department for the benefit of patients, both young and old. Read More

Cancer investigators led by researchers at Vanderbilt-Ingram Cancer Center (VICC) have co-developed a liquid biopsy blood-based assay used to identify specific gene mutations associated with the development or relapse of small-cell lung cancer (SCLC). Read More

Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer. Read More

Clinicians, investigators and cancer patients now have access to a new online search tool that provides more detailed information about clinical research trials available for cancer patients. Read More

Vanderbilt-Ingram Cancer Center (VICC) has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of adult patients with a specific type of lymphoma. VICC is the only cancer center in a seven-state region of the Southeast authorized to deliver the new immunotherapy. Read More

Members of the Vanderbilt University Medical Center (VUMC) community and others whose lives and careers have been influenced by legendary cancer investigator, educator and administrator Harold (Hal) Moses, M.D., have endowed the Linda and Harold L. Moses, M.D. Career Development Fund. Read More

Three breast cancer investigators from Vanderbilt-Ingram Cancer Center (VICC) have been awarded research grants from Susan G. Komen, a nonprofit foundation devoted to supporting cancer research, community health outreach, advocacy and public policy initiatives. Read More

Vanderbilt-Ingram Cancer Center (VICC) is offering an expressive writing course for cancer patients and others who have been affected by the disease. This year’s “Express Yourself: Fall Creative Writing Series” is provided to anyone interested in learning about expressive writing, and participants will have the opportunity to create original writing in a safe, supportive environment. Read More

David Penson, M.D., MPH, Paul V. Hamilton, M.D., and Virginia E. Howd Professor of Urologic Oncology and chair of the Department of Urologic Surgery, has been named an associate editor for The Journal of the National Cancer Institute (JNCI). Read More

Vanderbilt-Ingram Cancer Center (VICC) will sponsor an educational conference for kidney cancer patients, survivors and family members Saturday, Sept. 9, 8 a.m. – 2 p.m., in the Preston Research Building, Suite 898. Read More

A group of nationally recognized medical information and data management experts has recommended the development of new knowledge software applications that work alongside electronic health record systems (EHRs) to help practicing oncologists access and use the latest genomic information to assist in the treatment of cancer patients. Read More

Vanderbilt University Medical Center (VUMC) has been named to the Becker’s Hospital Review roster of 100 Hospitals and Health Systems with Great Oncology Programs. Read More

In her life, Jessi Zazu, 27, has toured the world as a musician in the group Those Darlins, recorded three studio albums, starred in music videos and exhibited her original artwork in individual and group art shows. Read More

Curiosity is the spark that has always energized and illuminated Eric Shinohara’s life — curiosity about the natural world, about other people and about how to help those individuals. Read More

Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients. Read More

Karen Munyon, MBA, director of Finance and Operations for Radiation Oncology at Vanderbilt University Medical Center (VUMC), has been appointed to the Tennessee Radiologic Imaging and Radiation Therapy Board of Examiners. She is one of nine individuals appointed by the Tennessee governor or state lawmakers to the newly created oversight board. Read More

The Nashville Sounds baseball team recently highlighted cancer care at Vanderbilt-Ingram Cancer Center (VICC) during a special “Cancer Awareness Night.” Read More

Yu Shyr, Ph.D., Harold L. Moses Professor of Cancer Research and director of the Vanderbilt Center for Quantitative Sciences, has been named chair of Vanderbilt’s Department of Biostatistics. He will assume the post Sept. 1. Read More